{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T04:00:43Z","timestamp":1790308843830,"version":"4.1.0"},"reference-count":20,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T00:00:00Z","timestamp":1786320000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T00:00:00Z","timestamp":1786320000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"funder":[{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["APP1109466"],"award-info":[{"award-number":["APP1109466"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Drug and Alcohol Review"],"published-print":{"date-parts":[[2026,9]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>The Australian Treatment Outcomes Profile (ATOP) is a brief clinical tool assessing substance use, health and well\u2010being used in Australian alcohol and other drug treatment services. It is validated for use with clients using alcohol, opioids and cannabis, but not yet for clients who primarily use methamphetamine.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      An embedded validation study was undertaken in treatment\u2010seeking adults enrolled in a randomised double\u2010blind placebo\u2010controlled trial of lisdexamfetamine for methamphetamine dependence with sites in New South Wales, South Australia and Victoria. Participant demographics were collected during study screening. The ATOP and comparators (Time Line Follow Back, Opiate Treatment Index, Depression Anxiety Stress Scale, WHOQOL\u2010BREF and Personal Wellbeing Index) were collected at baseline. Continuous ATOP items were analysed using Pearson's correlation coefficient, and dichotomous items were analysed using Fleiss's\n                      <jats:italic>\u03ba<\/jats:italic>\n                      . Agreement was rated as strong where measures were \u2265\u20090.50, moderate where agreement was 0.30\u20130.49, and weak where &lt;\u20090.30.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>One hundred and eighteen study participants (2018\u20132020) had data for concurrent validity analysis. Strong validity was demonstrated for physical health, psychological health, quality of life, injecting drug use and crime items, and for days of use for amphetamines, alcohol, cannabis and cocaine. There was weak validity for days of use for benzodiazepines. Heroin use days and other opioid use days were endorsed by fewer than five participants and were therefore unable to be assessed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion and Conclusions<\/jats:title>\n                    <jats:p>The ATOP is valid for use in a treatment\u2010seeking methamphetamine\u2010dependent population, expanding the range of tools for assessment and standardised outcome monitoring across different settings and services.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1111\/dar.70224","type":"journal-article","created":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T03:37:18Z","timestamp":1786419438000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Assessing the Concurrent Validity of the Australian Treatment Outcomes Profile in a Methamphetamine Dependent Treatment\u2010Seeking Population"],"prefix":"10.1111","volume":"45","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9178-9013","authenticated-orcid":false,"given":"Brendan","family":"Clifford","sequence":"first","affiliation":[{"name":"Alcohol and Drug Service St Vincent's Hospital Sydney  Sydney Australia"},{"name":"National Centre for Clinical Research on Emerging Drugs UNSW Sydney  Sydney Australia"},{"name":"New South Wales Drug and Alcohol Clinical Research and Improvement Network (DACRIN)  Sydney Australia"},{"name":"National Drug and Alcohol Research Centre UNSW Sydney  Sydney Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel M.","family":"Deacon","sequence":"additional","affiliation":[{"name":"New South Wales Drug and Alcohol Clinical Research and Improvement Network (DACRIN)  Sydney Australia"},{"name":"Specialty of Addiction Medicine, Faculty of Medicine and Health The University of Sydney  Sydney Australia"},{"name":"Drug and Alcohol Services South Eastern Sydney Local Health District  Sydney Australia"},{"name":"Centre for Alcohol and Other Drugs NSW Ministry of Health  Sydney Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristie","family":"Mammen","sequence":"additional","affiliation":[{"name":"New South Wales Drug and Alcohol Clinical Research and Improvement Network (DACRIN)  Sydney Australia"},{"name":"Drug and Alcohol Services South Eastern Sydney Local Health District  Sydney Australia"},{"name":"Centre for Alcohol and Other Drugs NSW Ministry of Health  Sydney Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krista J.","family":"Siefried","sequence":"additional","affiliation":[{"name":"Alcohol and Drug Service St Vincent's Hospital Sydney  Sydney Australia"},{"name":"National Centre for Clinical Research on Emerging Drugs UNSW Sydney  Sydney Australia"},{"name":"New South Wales Drug and Alcohol Clinical Research and Improvement Network (DACRIN)  Sydney Australia"},{"name":"National Drug and Alcohol Research Centre UNSW Sydney  Sydney Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadine","family":"Ezard","sequence":"additional","affiliation":[{"name":"Alcohol and Drug Service St Vincent's Hospital Sydney  Sydney Australia"},{"name":"National Centre for Clinical Research on Emerging Drugs UNSW Sydney  Sydney Australia"},{"name":"New South Wales Drug and Alcohol Clinical Research and Improvement Network (DACRIN)  Sydney Australia"},{"name":"National Drug and Alcohol Research Centre UNSW Sydney  Sydney Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas","family":"Lintzeris","sequence":"additional","affiliation":[{"name":"New South Wales Drug and Alcohol Clinical Research and Improvement Network (DACRIN)  Sydney Australia"},{"name":"Specialty of Addiction Medicine, Faculty of Medicine and Health The University of Sydney  Sydney Australia"},{"name":"Drug and Alcohol Services South Eastern Sydney Local Health District  Sydney Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2026,8,10]]},"reference":[{"key":"e_1_2_12_2_1","doi-asserted-by":"publisher","DOI":"10.1111\/add.16295"},{"key":"e_1_2_12_3_1","doi-asserted-by":"publisher","DOI":"10.1111\/dar.13588"},{"key":"e_1_2_12_4_1","doi-asserted-by":"publisher","DOI":"10.1097\/ADM.0000000000001311"},{"key":"e_1_2_12_5_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1360\u20100443.2008.02284.x"},{"key":"e_1_2_12_6_1","doi-asserted-by":"publisher","DOI":"10.1111\/add.15331"},{"key":"e_1_2_12_7_1","doi-asserted-by":"publisher","DOI":"10.1111\/dar.12083"},{"key":"e_1_2_12_8_1","doi-asserted-by":"publisher","DOI":"10.1111\/dar.13050"},{"key":"e_1_2_12_9_1","unstructured":"Australian Institute of Health and Welfare \u201cAlcohol and Other Drug Treatment Services in Australia Annual Report Amphetamines \u201d2025 cited October 19 2025 https:\/\/www.aihw.gov.au\/reports\/alcohol\u2010other\u2010drug\u2010treatment\u2010services\/alcohol\u2010other\u2010drug\u2010treatment\u2010services\u2010australia\/contents\/drugs\u2010of\u2010concern\/amphetamines."},{"key":"e_1_2_12_10_1","doi-asserted-by":"publisher","DOI":"10.1111\/add.16730"},{"key":"e_1_2_12_11_1","volume-title":"The ICD\u201010 Classification of Mental and Behavioural Disorders: Diagnostic Criteria for Research","author":"World Health Organization (WHO)","year":"1993"},{"key":"e_1_2_12_12_1","unstructured":"N.Lintzeris K.Mammen J.Holmes et\u00a0al. \u201cAustralian Treatment Outcomes Profile (ATOP) Manual 1: Using the ATOP With Individual Clients \u201d2020 https:\/\/www.seslhd.health.nsw.gov.au\/australian\u2010treatment\u2010outcomes\u2010profile."},{"key":"e_1_2_12_13_1","volume-title":"Timeline Follow Back: A Calendar Method for Assessing Alcohol and Drug Use (Users Guide)","author":"Sobell L.","year":"1996"},{"key":"e_1_2_12_14_1","doi-asserted-by":"publisher","DOI":"10.1037\/\/0022\u2010006x.68.1.134"},{"key":"e_1_2_12_15_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1360\u20100443.1992.tb02719.x"},{"key":"e_1_2_12_16_1","volume-title":"Manual for the Depression Anxiety Stress Scales","author":"Lovibond S.","year":"1995"},{"key":"e_1_2_12_17_1","doi-asserted-by":"publisher","DOI":"10.1023\/B:QURE.0000018486.91360.00"},{"key":"e_1_2_12_18_1","doi-asserted-by":"publisher","DOI":"10.1097\/00006842\u2010200203000\u201000008"},{"key":"e_1_2_12_19_1","volume-title":"Personal Wellbeing Index","author":"International Wellbeing Group","year":"2013"},{"key":"e_1_2_12_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbi.2008.08.010"},{"key":"e_1_2_12_21_1","doi-asserted-by":"publisher","DOI":"10.1111\/dar.13346"}],"container-title":["Drug and Alcohol Review"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/dar.70224","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/dar.70224","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/dar.70224","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T03:32:59Z","timestamp":1790307179000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/dar.70224"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,10]]},"references-count":20,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["10.1111\/dar.70224"],"URL":"https:\/\/doi.org\/10.1111\/dar.70224","archive":["Portico"],"relation":{},"ISSN":["0959-5236","1465-3362"],"issn-type":[{"value":"0959-5236","type":"print"},{"value":"1465-3362","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,10]]},"assertion":[{"value":"2025-12-02","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-07-20","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-08-10","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e70224"}}